NCT03383705

VBeam Prima for Treatment of Photoaged Facial Skin

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: Syneron Medical · Industry
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Accepted

Summary

This is an open-label, single-center study. Subjects in this study will receive up to four (4) facial treatments at 4-6 (±1) weeks interval, with the VBeam Prima device according to the study protocol. Subjects will return for follow-up (FU) visits at the clinic at 1 and 3 months following the last treatment.

Conditions

• Photoaged Facial Skin

Interventions

Type	Name	Description
DEVICE	VBeam Prima	Up to four treatments will be performed every 4-6 (±1) weeks.

Timeline

• Start date: 2017-11-15
• Primary completion: 2018-11-15
• Completion: 2018-11-15
• First posted: 2017-12-26
• Last updated: 2017-12-26

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study